Moderna expands COVID-19 vaccine supply agreement with U.K.

By The Science Advisory Board staff writers

November 30, 2020 -- Moderna has announced a supply agreement with the U.K. government for an additional 2 million doses of messenger RNA (mRNA)-1273, the company's COVID-19 vaccine, beginning in March 2021.

The U.K. government has now secured 7 million doses of Moderna's vaccine. Moderna is scaling up its global manufacturing to be able to deliver approximately 500 million doses per year and possibly up to 1 billion doses per year beginning in 2021. The firm is working with Lonza of Switzerland and ROVI of Spain for manufacturing and fill-finish processing outside the U.S.


Copyright © 2020 scienceboard.net
 


Email Address:

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.